101,99 €
101,99 €
inkl. MwSt.
Sofort per Download lieferbar
payback
0 °P sammeln
101,99 €
101,99 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
0 °P sammeln
Als Download kaufen
101,99 €
inkl. MwSt.
Sofort per Download lieferbar
payback
0 °P sammeln
Jetzt verschenken
101,99 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
0 °P sammeln
  • Format: PDF

CORONAVIRUS DISEASE 2019 (COVID-19) Provides comprehensive coverage of all key aspects of COVID-19, including: etiology, diagnosis, symptomatology, management, and treatment Coronavirus Disease 2019 (COVID-19): A Clinical Guide provides healthcare professionals at all levels with up-to-date knowledge about the clinical, epidemiological, genomic, virological, and radiologic features of COVID-19. Consolidating multiple systematic reviews and meta-analyses into a single volume, this comprehensive textbook also addresses health policies, mass casualty planning, healthcare worker safety, economic…mehr

  • Geräte: PC
  • mit Kopierschutz
  • eBook Hilfe
  • Größe: 109.44MB
Produktbeschreibung
CORONAVIRUS DISEASE 2019 (COVID-19) Provides comprehensive coverage of all key aspects of COVID-19, including: etiology, diagnosis, symptomatology, management, and treatment Coronavirus Disease 2019 (COVID-19): A Clinical Guide provides healthcare professionals at all levels with up-to-date knowledge about the clinical, epidemiological, genomic, virological, and radiologic features of COVID-19. Consolidating multiple systematic reviews and meta-analyses into a single volume, this comprehensive textbook also addresses health policies, mass casualty planning, healthcare worker safety, economic impact, lessons for future outbreaks, and other para-clinical and social aspects of the COVID-19 pandemic. The text presents a thorough summary and critical analysis of COVID-19 based on an exhaustive review of recently published literature and data. Topics include the virologic characteristics of SARS-CoV-2, pulmonary and extrapulmonary manifestations and consequences of COVID-19, prevention and transmission control, the pandemic's indirect impact to the care and management of other diseases, passive immunotherapy and its implications, diagnostic and treatment approaches for critically ill patients, and more. Edited by leading -practitioners at the forefront of COVID-19 research, this invaluable resource: * Integrates clinical, radiological, and epidemiological data and discussion of prevention, diagnosis, and treatment * Reviews the epidemiology, mechanisms of action, manifestations, and management of cardiovascular, neurological, and pulmonary diseases associated with COVID-19 * Covers diagnostic technologies, includes radiologic imaging, and RT-PCR testing * Explores therapeutic approaches for managing a variety of complications * Discusses post-vaccination symptom management and implications of immunization * Addresses COVID-19 in pediatrics, in cancer patients, and in patients with lung disease, diabetes, -hypertension, obesity, and other underlying conditions Coronavirus Disease 2019 (COVID-19): A Clinical Guide is an indispensable source of information for all clinicians, researchers, epidemiologists, nurses, radiologists, and healthcare managers working to address any aspect of the COVID-19 pandemic.

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Autorenporträt
Ali Gholamrezanezhad, Associate Professor of Clinical Imaging, Keck School of Medicine, University of Southern California (USC), Los Angeles, California, USA. Since the outbreak of the pandemic, Dr. Gholamrezanezhad has been leading an international team of researchers, physicians, and scientists to investigate COVID-19. Michael P. Dube, Professor of Medicine, Division of Infectious Diseases, Keck School of Medicine, University of Southern California (USC), Los Angeles, California, USA. Dr. Dube has been active in clinical care and clinical trials of COVID-19 therapeutics and vaccines and serves on a variety of committees at the local and state levels addressing the pandemic.